XERS vs BBAI Comparison

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

BigBear.ai Holdings Inc is a provider of mission-ready artificial intelligence (AI) technology originally founded to serve defense and national security mission customers. The Company provides Edge AI-powered decision intelligence solutions, including artificial intelligence and machine learning, generative AI, data science, computer vision, biometrics, cyber, cloud solutions, and systems integration. Customers rely on its predictive analytics capabilities in mission-based operating environments. Its solutions are organized into five markets, including Supply Chain & Logistics Solutions, Cybersecurity Solutions, Autonomous Systems Solutions, Digital Identity Services, and the Ask Sage Platform.